Alecensa 150 MG capsule UU 240S
Ended Awarded Last action
- Contract number
- SPE2DR26FMEF6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $56,058
Award facts
- Contract value 100% obligated
- $56,057.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $56,057.84 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 240 units of Alecensa 150 mg capsules. The delivery order, issued on January 14, 2026, with an ultimate completion date of February 5, 2026, utilizes firm fixed-price pricing with no set-aside designation. DMS Pharmaceutical Group Inc. will serve as the sole contractor on this award, with no subcontractors involved.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to ensure reliable pharmaceutical supply chains for Department of Defense military healthcare facilities worldwide. The parent contract, valued at $499,999,999 and awarded in November 2025, carries a completion date of December 31, 2036. Alecensa, an oncology treatment medication, represents one component of the company's extensive pharmaceutical product portfolio that includes branded and generic prescription drugs, biologics, vaccines, and medical consumables. DMS Pharmaceutical Group's established performance across numerous federal delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements supporting global military medical operations.
Quick answers
Who was awarded contract SPE2DR26FMEF6?
SPE2DR26FMEF6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FMEF6 worth?
The government has obligated $56,058 on SPE2DR26FMEF6.
Is contract SPE2DR26FMEF6 an order under another contract?
Yes. SPE2DR26FMEF6 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMEF6 competed?
The extent of competition for SPE2DR26FMEF6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award